Biblio
Export 1170 results:
Author Title Type [ Year] Filters: First Letter Of Last Name is R [Clear All Filters]
“Cognitive Status, Gray Matter Atrophy, and Lower Orthostatic Blood Pressure in Older Adults.”, J Alzheimers Dis, vol. 57, no. 4, pp. 1239-1250, 2017.
, “Co-Localization of Glia Maturation Factor with NLRP3 Inflammasome and Autophagosome Markers in Human Alzheimer's Disease Brain.”, J Alzheimers Dis, vol. 60, no. 3, pp. 1143-1160, 2017.
, “Combustion-Derived Nanoparticles in Key Brain Target Cells and Organelles in Young Urbanites: Culprit Hidden in Plain Sight in Alzheimer's Disease Development.”, J Alzheimers Dis, vol. 59, no. 1, pp. 189-208, 2017.
, “A Common Variant of IL-6R is Associated with Elevated IL-6 Pathway Activity in Alzheimer's Disease Brains.”, J Alzheimers Dis, vol. 56, no. 3, pp. 1037-1054, 2017.
, “Comparison of Gait Parameters for Predicting Cognitive Decline: The Mayo Clinic Study of Aging.”, J Alzheimers Dis, vol. 55, no. 2, pp. 559-567, 2017.
, “Comprehensive Quantitative Profiling of Tau and Phosphorylated Tau Peptides in Cerebrospinal Fluid by Mass Spectrometry Provides New Biomarker Candidates.”, J Alzheimers Dis, vol. 55, no. 1, pp. 303-313, 2017.
, “Conscientiousness is Negatively Associated with Grey Matter Volume in Young APOE ɛ4-Carriers.”, J Alzheimers Dis, vol. 56, no. 3, pp. 1135-1144, 2017.
, “Cortical Thickness and Depressive Symptoms in Cognitively Normal Individuals: The Mayo Clinic Study of Aging.”, J Alzheimers Dis, vol. 58, no. 4, pp. 1273-1281, 2017.
, “A Critical Assessment of Research on Neurotransmitters in Alzheimer's Disease.”, J Alzheimers Dis, vol. 57, no. 4, pp. 969-974, 2017.
, “Cross-Sectional and Longitudinal Cognitive Correlates of FDDNP PET and CSF Amyloid-β and Tau in Parkinson's Disease1.”, J Alzheimers Dis, vol. 55, no. 3, pp. 1261-1272, 2017.
, “Cross-Sectional and Longitudinal Cognitive Correlates of FDDNP PET and CSF Amyloid-β and Tau in Parkinson's Disease1.”, J Alzheimers Dis, vol. 55, no. 3, pp. 1261-1272, 2017.
, “Curcumin Inhibits Tau Aggregation and Disintegrates Preformed Tau Filaments in vitro.”, J Alzheimers Dis, vol. 60, no. 3, pp. 999-1014, 2017.
, “Current Approaches and Clinician Attitudes to the Use of Cerebrospinal Fluid Biomarkers in Diagnostic Evaluation of Dementia in Europe.”, J Alzheimers Dis, vol. 60, no. 1, pp. 201-210, 2017.
, “Cyclic cis-Locked Phospho-Dipeptides Reduce Entry of AβPP into Amyloidogenic Processing Pathway.”, J Alzheimers Dis, vol. 55, no. 1, pp. 391-410, 2017.
, “Deficit in Central Auditory Processing as a Biomarker of Pre-Clinical Alzheimer's Disease.”, J Alzheimers Dis, vol. 60, no. 4, pp. 1589-1600, 2017.
, “Deleterious Effect of Butyrylcholinesterase K-Variant in Donepezil Treatment of Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 56, no. 1, pp. 229-237, 2017.
, “Deleterious Effect of Butyrylcholinesterase K-Variant in Donepezil Treatment of Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 56, no. 1, pp. 229-237, 2017.
, “Depressive Symptoms and Tau Accumulation in the Inferior Temporal Lobe and Entorhinal Cortex in Cognitively Normal Older Adults: A Pilot Study.”, J Alzheimers Dis, vol. 59, no. 3, pp. 975-985, 2017.
, “Detecting At-Risk Alzheimer's Disease Cases.”, J Alzheimers Dis, vol. 60, no. 1, pp. 97-105, 2017.
, “Development of Nasal Lipid Nanocarriers Containing Curcumin for Brain Targeting.”, J Alzheimers Dis, vol. 59, no. 3, pp. 961-974, 2017.
, “Diabetes and Alzheimer's Disease: Can Elevated Free Copper Predict the Risk of the Disease?”, J Alzheimers Dis, vol. 56, no. 3, pp. 1055-1064, 2017.
, “Diabetes is Not Associated with Alzheimer's Disease Neuropathology.”, J Alzheimers Dis, vol. 60, no. 3, pp. 1035-1043, 2017.
, “Diagnostic Accuracy of a Combined Analysis of Cerebrospinal Fluid t-PrP, t-tau, p-tau, and Aβ42 in the Differential Diagnosis of Creutzfeldt-Jakob Disease from Alzheimer's Disease with Emphasis on Atypical Disease Variants.”, J Alzheimers Dis, vol. 55, no. 4, pp. 1471-1480, 2017.
, “Diagnostic Accuracy of a Combined Analysis of Cerebrospinal Fluid t-PrP, t-tau, p-tau, and Aβ42 in the Differential Diagnosis of Creutzfeldt-Jakob Disease from Alzheimer's Disease with Emphasis on Atypical Disease Variants.”, J Alzheimers Dis, vol. 55, no. 4, pp. 1471-1480, 2017.
, “The Diagnostic and Prognostic Value of Neuropsychological Assessment in Memory Clinic Patients.”, J Alzheimers Dis, vol. 55, no. 2, pp. 679-689, 2017.
,